PAPILLARY THYROID MICROCARCINOMA AND FOLLICULAR THYROID ADENOMA: IMPACT OF CLINICAL ACCOMPANIEMENT

Authors

  • Dinets A. V. Kyiv City Teaching Endocrinological Center, Kyiv
  • Hulchiy M. V. Kyiv City Teaching Endocrinological Center, Kyiv
  • Tsimbaliuk C. M. Kyiv City Teaching Endocrinological Center, Kyiv
  • Olyinyk O. B. Kyiv City Teaching Endocrinological Center, Kyiv

DOI:

https://doi.org/10.21856/j-PEP.2012.2.04

Keywords:

papillary thyroid carcinoma, follicular thyroid adenoma

Abstract

The aim of the study was to analyze and estimate clinical and pathological features of papillary thyroid microcarcinoma concurrent with follicular thyroid adenoma. Our findings suggest PTMC accompanied by follicular thyroid adenoma to have a less aggressive biological behavior compared to pure PTMC that might be considered in routine clinical practice. Moreover, PTMC associated with follicular thyroid adenoma may have prognostic importance for closer and long-time follow up of patients.

References

DeLellis, R. A. Pathology and genetics of tumours of endocrine organs IARC/World Health Organization Classification of Tumors [Text] / R. A. DeLellis. — Lyon: IARC Press, 2004. — 320 p.

Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period [Text] / I. D. Hay, M. E. Hutchinson, T. Gonzalez-Losada [et al.] // Surgery. — 2008. — Vol. 144. — P. 980–987.

Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination [Text] / Y. Ito, T. Uruno, Y. Takamura [et al.] // Oncology. —

— Vol. 68. — P. 87–96.

Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis [Text] / J. Y. Kwak, E. K. Kim, M. J. Kim [et al.] // Ann. Surg. Oncol. — 2009. — Vol. 16. — P. 1348–1355.

Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience [Text] / M. R. Pelizzo, I. M. Boschin, A. Toniato [et al.] // Nucl. Med. Commun. — 2004. — Vol. 25. — P. 547–552.

Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients [Text] / E. Roti, R. Rossi, G. Trasforini [et al.] // J. Clin. Endocrinol. Metabol. — 2006. — Vol. 91. — P. 2171–2178.

Особливостi pаку щитоподiбної залози на тлi iншої тиpеоїдної патологiї [Text] / М. В. Гульчiй, О. Б. Олiйник, А. В. Сташук [та iн.] // Ендокpинологiя. — 2001. — № 6. — С. 75.

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated

thyroid cancer [Text] / D. S. Cooper,G. M. Doherty, B. R. Haugen [et al.] // Thyroid. — 2009. — Vol. 19. — P. 1167–1214.

Perros, P. Introduction to the updated guidelines on the management of thyroid cancer [Text] / P. Perros // Clin. Med. — 2007. — Vol. 7. — P. 321–322.

Kuru, B. The 2009 revised american thyroid association guidelines for thyroid cancer: the extent of surgery for thyroid carcinoma less than one and one half centimeters or low-risk thyroid carcinoma [Text] / B. Kuru, K. Topgul // Thyroid. — 2012. — Vol. 22. — P. 225–226.

SEOM clinical guidelines for the treatment of thyroid cancer [Text] / J. Martinez Trufero, J. Capdevilla, J. J. Cruz [et al.] // Clin. Transl. Oncol. — 2011. — Vol. 13. — P. 574–579.

Guidelines of the French society of endocrinology for the management of thyroid nodules [Text] / J. L. Wemeau, J. L. Sadoul, M. d’Herbomez [et al.] // Ann. Endocrinol. — 2011. — Vol. 72. — P. 251–281.

Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+-binding protein S100A6 in papillary thyroid carcinoma [Text] / A. Sofiadis, A. Dinets, L. M. Orre [et al.] // Thyroid. — 2010. — Vol. 20. — P. 1067–1076.

Incidental papillary microcarcinoma of the thyroid-factors affecting lymph node metastasis [Text] / K. Gulben, U. Berberoglu, O. Celen [et al.] // Langenbecks Arch. Surg. — 2008. — Vol. 393. — P. 25–29.

Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area [Text] / C. P. Lombardi, R. Bellantone, C. De Crea [et al.] // World. J. Surg. — 2010. — Vol. 34. —

P. 1214–1221.

Incidental papillary microcarcinoma of the thyroidfurther evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up [Text] / N. Neuhold, A. Schultheis, M. Hermann [et al.] // Ann. Surg.

Oncol. — 2011. — Vol. 18. — P. 3430–3436.

’Aggressive papillary’ thyroid microcarcinoma [Text] / C. Page, A. Biet, P. Boute [et al.] // Europ. Arch. Otorhinolaryngol. — 2009. — Vol. 266. — P. 1959–63.

Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size [Text] / K. J. Lee, Y. J. Cho, S. J. Kim [et al.] // World. J. Surg. — 2011. — Vol. 35. — P. 318–323.

Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients [Text] / G. Mercante, A. Frasoldati, C. Pedroni [et al.] // Thyroid. — 2009. — Vol. 19. —

P. 707–716.

A review of 227 cases of small papillary thyroid carcinoma [Text] / H. Zuo, W. Tang, H. Yasuoka [et al.] // Europ. J. Surg. Oncol. — 2007. — Vol. 33. — P. 370–375.

Downloads

Published

2012-06-04

How to Cite

Dinets, A. V., Hulchiy, M. V., Tsimbaliuk, C. M., & Olyinyk, O. B. (2012). PAPILLARY THYROID MICROCARCINOMA AND FOLLICULAR THYROID ADENOMA: IMPACT OF CLINICAL ACCOMPANIEMENT. Problems of Endocrine Pathology, 40(2), 20-25. https://doi.org/10.21856/j-PEP.2012.2.04

Issue

Section

CLINICAL ENDOCRINOLOGY